Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016;7(1):57-60.
Epub 2016 Feb 1.

Croup as Unusual Presentation of Post-transplantation Lymphoproliferative Disorder after Liver Transplantation in an 18-month-old Child

Affiliations
Case Reports

Croup as Unusual Presentation of Post-transplantation Lymphoproliferative Disorder after Liver Transplantation in an 18-month-old Child

A Keshtkari et al. Int J Organ Transplant Med. 2016.

Abstract

Post-transplantation lymphoproliferative disorder (PTLD) is a serious complication of solid organ transplantation that occurs due to immunosuppression and other risk factors. PTLD may present with involvement of other organs and with unusual presentation. The presentation is often extranodal (e.g., in the gastrointestinal tract, lung, or the central nervous system). Herein, we report on a 1.5-year-old girl who underwent liver transplantation almost 5 months prior to admission. She was on medications such as tacrolimus and prednisolone. Her presentation was started with symptoms of the upper respiratory infection followed by croupy cough and respiratory distress with no response to usual treatments. She had respiratory arrest during broncoscopy. Therefore, emergency tracheostomy was done. Biopsy from the paratracheal mass revealed large B cell non-Hodgkin lymphoma (PTLD, monomorphic and high grade). This case presentation shows that persistent upper airway symptoms, particularly stridor and croupy cough, in children who underwent liver transplant should be further evaluated; the physician needs to have a high degree of clinical suspicion for the diagnosis of PTLD in this situation.

Keywords: Immunosuppression; Liver transplantation; Lymphoproliferative disorders; Prednisolone; Rituximab; Tacrolimus.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Heterogenous enhancing mass lesion measuring 33×27 mm seen at the level of the epiglottis in the midline and right paramedial aspect with pressure effect over airways leading to airway obstruction
Figure 2
Figure 2
Immunohistochemical staining showing large B-cell lymphoma: Cells are positive for CD20, CD43, and CD79, and are negative for CD3

References

    1. Friedberg JW, Aster JC. [(Accessed september 5, 2013)]. Available from: http://www.uptodate.com/contents/epidemiology-clinical-manifestations-an...
    1. Kalinova L, Indrakova J, Bachleda P. Post-Transplant lymphoproliferative disorder. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009;153:251–7. - PubMed
    1. Newell KA, Alonso EM, Whitington PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation. 1996;62:370–5. - PubMed
    1. Kleinman RE, Goulet OJ, Sanderson PH, et al. Walker’s Pediatric gastrointestinal disease. 5th ed. . Hamilton, BC Decker Inc; 2008.
    1. Ho M, Jaffe R, Miller G. The frequency of epstein-barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children. Transplantation. 1988;45:719–27. - PMC - PubMed

Publication types

LinkOut - more resources